In pigs with induced myocardial infarction, liraglutide did not change relative infarct size compared with controls (no intergroup differences).
In plain wordsIn pigs with a heart attack, liraglutide did not change infarct size compared with controls.
- Peptide
- Liraglutide
- Outcome
- No significant changeRelative infarct size
- Study
pign = 58
Closed-chest pig model of 45 min LAD occlusion and reperfusion- Comparator
- Controls and ischemic postconditioning
- Outcome group
- Heart function · Cardiovascular
- Studied dose
- Dose not stated · intravenousAs given in this study (pig).
Measurements
- Relative infarct size
- 57%
- overall mean
Source sentences
No intergroup differences in relative infarct size were detected (overall mean 57 ± 3%; p = 0.68).
3 context sentences(design, population, supporting numbers)
In our closed-chest pig-model, we were unable to detect any cardioprotective effect of liraglutide or ischemic postconditioning either alone or combined.
Fifty-eight non-diabetic female Danish Landrace pigs (60 ± 10kg) were randomly assigned to four groups.
Group 1 (n = 14) was treated with i.v. liraglutide after 15 min of ischemia.